Severity
Moderate
FDA Devices recall · Reported March 26, 2014
Some of the discs may not be impregnated with the antibiotic.
Remel Inc recalled Oxoid Vancomycin 30 mcg, each cartridge contains 50 susceptibility discs, CT0058B. The f… - a moderate-severity action.
Oxoid Vancomycin 30 mcg, each cartridge contains 50 susceptibility discs, CT0058B. The f… was recalled by Remel Inc in March 26, 2014. Reason: Some of the discs may not be impregnated with the antibiotic.. Check the official notice for the remedy. Verify recall #Z-1246-2014 with the FDA Devices before acting.
The recall
Remel Inc issued this moderate-severity FDA Devices recall-Some of the discs may not be impregnated with the antibiotic..
Sourced from official FDA Devices enforcement records. Verify recall #Z-1246-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1246-2014) was formally reported on March 26, 2014, with the manufacturer initiating the action on February 18, 2014. It is classified under Moderate severity (Class II), with a current status of Terminated. Remel Inc is listed as the recalling firm, operating out of Lenexa, KS. Federal records list the affected scope as 40/5/50-disc cartridge packages.
The documented reason for this recall is: Some of the discs may not be impregnated with the antibiotic. Distribution data in the federal record shows the product reached: Nationwide Distribution. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
40/5/50-disc cartridge packages
Related Recalls
6
3 from same agency
Oxoid Vancomycin 30 mcg, each cartridge contains 50 susceptibility discs, CT0058B. The firm name on the label is Oxoid Ltd., Basingstoke, Hampshire, England. Used in the semi-quantitative agar diffusion test method for in-vitro susceptibility testing.
Some of the discs may not be impregnated with the antibiotic.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1246-2014 |
| Date reported | March 26, 2014 |
| Date initiated | February 18, 2014 |
| Recalling firm | Remel Inc |
| Firm location | Lenexa, KS |
| Affected scope | 40/5/50-disc cartridge packages |
| Distribution | Nationwide Distribution |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported March 26, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.